3-iodobenzylguanidine has been researched along with Fever of Unknown Origin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coogan, A; de St Maurice, A; Frangoul, H; Williams, JV | 1 |
| Borght, TV; Krug, B; Lacrosse, M; Luyx, D; Pirson, AS; Tuerlinckx, D | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Fever of Unknown Origin
| Article | Year |
|---|---|
Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Catheterization, Central Venous; Child; Combined Modality Therapy; Fatal Outcome; Female; Fever of Unknown Origin; Humans; Immunocompromised Host; Malassezia; Mycoses; Neuroblastoma; Splenic Diseases; Stem Cell Transplantation | 2014 |
Additional value of I-123 MIBG SPECT in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Pain; Child, Preschool; Fever of Unknown Origin; Humans; Hypoventilation; Lung Neoplasms; Male; Neuroblastoma; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |